APA (7th ed.) Citation

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., . . . Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: Study protocol for a randomised controlled trial (ELAD study). Current controlled trials in cardiovascular medicine, 20(1), 191-10. https://doi.org/10.1186/s13063-019-3259-x

Chicago Style (17th ed.) Citation

Femminella, Grazia Daniela, et al. "Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimer’s Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study)." Current Controlled Trials in Cardiovascular Medicine 20, no. 1 (2019): 191-10. https://doi.org/10.1186/s13063-019-3259-x.

MLA (9th ed.) Citation

Femminella, Grazia Daniela, et al. "Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimer’s Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study)." Current Controlled Trials in Cardiovascular Medicine, vol. 20, no. 1, 2019, pp. 191-10, https://doi.org/10.1186/s13063-019-3259-x.